Pharmaceuticals & Therapeutics

New data shows automated systems are slashing drug approval times and saving patients millions, offering a glimpse into a future with fewer healthcare hurdles.

A new partnership embeds Eli Lilly's powerful AI models into CDD Vault, giving smaller biotechs unprecedented access to big pharma's discovery tools.

The 12th Annual Ride of Hope adds new challenging routes to honor Terry's legacy, channeling funds into cutting-edge precision cancer research.

A new purpose-built lab, Toronto's first in 20 years, attracts a major cell therapy firm, signaling a turning point for Canada's life sciences sector.

A first-in-class drug for anxiety has entered patient trials, offering a novel approach that could reshape mental healthcare for millions.

New projects leverage AI, gene therapy advances, and diverse workforce initiatives to bolster America's manufacturing and secure its talent pipeline.

A new VisitOrlando member is changing family airport transfers with airline-level safety standards, complimentary car seats, and a pilot's precision.

Diagnostics Direct wins a Johns Hopkins award for a rapid test that detects active syphilis, promising same-day diagnosis and treatment to combat rising rates.

An award-winning technology is transforming how hospitals treat a deadly diabetic complication in children, minimizing errors and improving patient safety.

A new study reveals a sharp drop in prescription fills at just $35, highlighting a critical affordability crisis that even insured patients can't escape.

Nourish lands $100M to expand its AI-powered metabolic clinic, blending dietitian care with technology to reverse chronic disease and cut healthcare costs.

A new partnership embeds specialty drug ordering into clinic software, promising to boost efficiency and patient care in the booming infusion market.

New research on the gut-brain axis and smarter antibiotic use is transforming veterinary medicine, moving from theory to practice for healthier pets.

Greenix acquires Insight Pest Solutions' MA and NH branches, signaling a major move in its aggressive, eco-conscious national expansion strategy.

A breakthrough shell-less egg system hatches live chicks, paving the way for the moa's return and offering new hope for today's endangered birds.

Natural Alternatives International posts a 23% sales surge but a wider net loss, betting on new financing and product innovation to fix profitability woes.

New report reveals how manual database changes expose financial firms to regulatory fines and AI-driven attacks, creating a critical operational risk.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

With backing from Bain Capital and Armistice, the life sciences firm's latest offering aims to fund its push to automate pharmaceutical quality control.

Kidney care giant DaVita unveils ambitious 2030 targets for transplants, health equity, and sustainability, raising the bar for the healthcare industry.